Skip to content
lifestyle.imone2015.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
August 11, 2026
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
August 10, 2026
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1×1 Conference
August 4, 2026
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
May 14, 2026
iMDx to Release First Quarter 2026 Results on May 13, 2026
May 6, 2026
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
April 14, 2026
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
March 20, 2026
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
March 13, 2026
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
March 3, 2026
iMDx Announces $26.0 Million Registered Direct Offering
February 20, 2026